In 2019 MC closed its inaugural investment in a biotechnology business based in Cape Town, thus executing on its intention to be an investor in Healthcare technology. Hyrax Biosciences produces DNA analysis software that:
• Enables early detection of cancer
• Informs personalised treatment for a range of diseases
GET IN TOUCH